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The acrosome is a membrane-limited granule that overlies the nucleus of the mature spermatozoon. In response to physiological or
pharmacological stimuli, sperm undergo calcium-dependent exocytosis termed the acrosome reaction, which is an absolute prerequisite for
fertilization. Protein tyrosine phosphorylation and dephosphorylation are mechanisms by which multiple cellular events are regulated. Here
we report that calcium induces tyrosine phosphorylation in streptolysin O (SLO)-permeabilized human sperm. As expected, pretreatment
with tyrphostin A47—a tyrosine kinase inhibitor—abolishes the calcium effect. Interestingly, the calcium-induced increase in tyrosine
phosphorylation has a functional correlate in sperm exocytosis. Masking of phosphotyrosyl groups with a specific antibody or inhibition of
tyrosine kinases with genistein, tyrphostin A47, and tyrphostin A51 prevent the acrosome reaction. By reversibly sequestering intra-
acrosomal calcium with a photo-inhibitable chelator, we show a requirement for protein tyrosine phosphorylation late in the exocytotic
pathway, after the efflux of intra-acrosomal calcium. Both mouse and human sperm contain highly active tyrosine phosphatases. Importantly,
this activity declines when sperm are incubated under capacitating conditions. Inhibition of tyrosine phosphatases with pervanadate, bis(N,N-
dimethylhydroxoamido)hydroxovanadate, ethyl-3,4-dephostatin, and phenylarsine oxide prevents the acrosome reaction. Our results show
that both tyrosine kinases and phosphatases play a central role in sperm exocytosis.
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Exocytosis is a highly regulated, multistage process
including targeting, tethering, docking, and fusion of secre-
tory vesicles with the plasma membrane. During the last few
years, several molecules involved in this complex cascade
of events have been identified (Jahn and Sudhof, 1999).
Protein tyrosine phosphorylation is an essential element in
the control of fundamental cellular signaling events in-
volved in growth, proliferation, and differentiation, includ-
ing regulated exocytosis. In some cases, secretion depends
on the phosphorylation of proteins on one or more tyrosine0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.09.032
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E-mail address: ctomes@fcm.uncu.edu.ar (C.N. Tomes).residues (Inoue et al., 2002; Sada et al., 2002) whereas, in
others, it is dephosphorylation that governs exocytosis
(Sterling et al., 2003). The initiation, extent, and termination
of tyrosine phosphorylation is determined by the concerted
activities of the phosphorylating (protein tyrosine kinases,
PTK) and dephosphorylating (protein tyrosine phospha-
tases, PTP) enzymes. Both PTK (see, for instance, Cox et
al., 1996; Kim et al., 1999; Parravicini et al., 2002; Zhang et
al., 2002a) and PTP (Chen and Geng, 2001; Ostenson et al.,
2002) have been implicated in secretion. Nevertheless, the
specific protein substrates, as well as their regulation,
remain largely unidentified. Also unknown is the exact
stage of the exocytotic reaction where these proteins play
their part.
Exocytosis of the acrosome (the acrosome reaction, AR)
is a terminal morphological alteration that sperm must
undergo before penetration of the extracellular coat of the
egg (zona pellucida). Although exocytosis of the acrosomal
vesicle has some unique properties, the emerging body of
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and regulatory components as those characterized for other
secretory events (Tomes et al., 2002 and references therein).
Tyrosine phosphorylation appears to display a key role in
several aspects of sperm function. For instance, an increase
in protein tyrosine phosphorylation has been shown to
accompany capacitation, the acquired ability of sperm to
interact productively with eggs (reviewed in Visconti and
Kopf, 1998; Visconti et al., 1998). Accordingly, decapaci-
tation by seminal plasma decreases both protein tyrosine
phosphorylation and the subpopulation of cells exhibiting
hyperactivated motility in ejaculated human sperm (Tomes
et al., 1998). Protein tyrosine phosphorylation has been
implicated in mammalian sperm AR since treatment with
PTK inhibitors can block zona pellucida- (Leyton et al.,
1992; Pukazhenthi et al., 1998) and progesterone- (Kirk-
man-Brown et al., 2002; Luconi et al., 1995; Meizel and
Turner, 1996; Tesarik et al., 1993) induced exocytosis.
Whether regulation of sperm protein phosphotyrosine con-
tent occurs through the activation of PTK, the inhibition of
PTP, or both remains to be elucidated. Data supporting the
involvement of PTKs has been derived from the identifica-
tion of the src-related PTK c-yes in human sperm on one
hand and the use of specific inhibitors on the other (see
Leclerc and Goupil, 2002 and references therein). In con-
trast, information regarding the presence and role of PTPs in
sperm function is lacking.
Here, we use permeabilized human sperm to assess the
role of protein tyrosine phosphorylation in acrosomal re-
lease. We find that challenging with calcium induces protein
tyrosine phosphorylation on the sperm head in two waves,
one preceding and one following acrosomal calcium efflux.
We also show that both PTK and PTP activities are required
in the signaling cascade leading to sperm exocytosis.Materials and methods
Reagents
Streptolysin O (SLO) was obtained from Corgenix
(Peterborough, UK). Tyrphostin A47 was from LC Labora-
tories (Woburn, MA). bis(N,N-dimethylhydroxoamido)hy-
droxovanadate (DMHV) and ethyl 3,4-dephostatin were
from Calbiochem (San Diego, CA). Mouse monoclonal
antiphosphotyrosine antibody (clone 4G10, subclass IgG2b)
(Druker et al., 1989) was from Upstate Biotechnology
Incorporated (UBI, Lake Placid, NY). Another mouse
monoclonal to phosphotyrosine (clone PY20, subclass
IgG2b) (Glenney et al., 1988) was purchased from ICN
(Aurora, OH). Monoclonal anti-PTP1B antibody, clone 15
(purified IgG2a) was from Transduction Laboratories (Lex-
ington, KY). Mouse monoclonal anti-PTP1B, clone FG6-
1G (purified IgG2a) (Schievella et al., 1993) was a kind gift
from Dr. Nicholas Tonks (Cold Spring Harbor Laboratory).
Horseradish peroxidase and TRITC-conjugated goat anti-mouse-IgG were from Kirkegaard and Perry Laboratories
Inc (KPL, Gaithersburg, MD). Reduced, carboxyamidome-
thylated, and maleylated lysozyme (RCML) phosphorylated
on tyrosyl residues prepared as in Tonks et al. (1988a) was a
gift from Dr. Nicholas Tonks. 32P-labeled poly(glutamic
acid-tyrosine) (random copolymer), 4:1 ratio, ([32P]poly
(Glu-Tyr)) prepared as in Burridge and Nelson (1995) was
a gift from Dr. Keith Burridge (University of North Caro-
lina, Chapel Hill). Nickel–nitrilotriacetic acid agarose was
from Qiagen (Hilden, Germany) and glutathione–sepharose
was from Amersham Biosciences Argentina (Buenos Aires,
Argentina). Prestained molecular weight standards were
from BRL-Life Technologies, Inc. (Gaithersburg, MD). O-
nitrophenyl EGTA-AM (EGTA-NP) was from Molecular
Probes (Eugene, OR). Methanol was purchased from Merck
Quı´mica (Buenos Aires, Argentina). All other chemicals
were reagent or analytical grade and were purchased from
Sigma Chemical Co. (St Louis, MO).
The expression plasmid pGEX2T containing the cDNA-
encoding human Rab3A was generously provided by Drs.
M.I. Colombo and P.D. Stahl (Washington University, St.
Louis, MO). GST-Rab3A was expressed in Escherichia coli
strain XL1-blue (Stratagene, La Jolla, CA), purified, preny-
lated, and activated as previously described (Yunes et al.,
2000). A plasmid encoding the light chain of BoNT/E
(BoNT/E-LC) was a kind gift from Dr. T. Binz (Medizinische
Hochschule Hannover, Hannover, Germany). His6-tagged
BoNT/E-LC was expressed and purified as in Vaidyanathan
et al. (1999).
Human sperm preparation procedure
After at least 2 days of abstinence, semen samples were
provided by masturbation from healthy volunteer donors
who were free from sexually transmitted diseases. Semen
was allowed to liquefy for 30–60 min at 37jC. For Western
blot and PTP experiments, sperm were isolated on a
discontinuous two-step PercollR (Pharmacia, Uppsala, Swe-
den) gradient. Sperm washed with phosphate buffered saline
(PBS) were incubated F1 mM pervanadate (made fresh by
mixing stocks of H2O2 and Na3VO4) for 15 min at 37jC,
and lysed to extract proteins immediately (noncapacitated
samples) or capacitated in Human Tubal Fluid media (Irvine
Scientific, Santa Ana, CA) supplemented with 7.5% human
serum (HTF media) at a concentration of 5–10  106/ml at
37jC in a humidified atmosphere of 5% CO2 in air for 5 h.
Where indicated, an additional 3 h incubation F50 AM
tyrphostin A47 and/or various concentrations of sodium
pervanadate in HTF were performed. After removing HTF
by washing twice with PBS (200  g for 10 min), sperm
pellets were processed for SDS-PAGE or for phosphatase
assays. Total motility was evaluated by diluting 2 Al of
sperm suspension with 8 Al of HTF on a glass slide,
covering the suspension with a 22  22 mm2 coverslip
(thickness #1), and examining with phase contrast optics at
a magnification of 400. Multiple fields were viewed and
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ing flagellar movement. Viability was measured with 1 Ag/
ml propidium iodide (Molecular Probes); the percentage of
live sperm was estimated by counting >100 sperm with
epifluorescence optics at a magnification of 400.
SLO permeabilization and AR assay
For AR assays, indirect immunofluorescence, and con-
focal microscopy, highly motile sperm were recovered
following a swim-up separation for 1 h in Gamete Prepara-
tion Medium (GPM, Aubonne, Switzerland) at 37jC in an
atmosphere of 5% CO2–95% air. Concentration was then
adjusted to 5–10  106/ml, and incubation proceeded for at
least 2 h under conditions that support capacitation (GPM
medium, 37jC, 5% CO2–95% air). Permeabilization was
accomplished as described (Yunes et al., 2000). Briefly,
washed spermatozoa were resuspended in cold PBS con-
taining 0.4 unit/ml SLO for 15 min at 4jC. Cells were
washed once with PBS, resuspended in ice-cold sucrose
buffer (250 mM sucrose, 20 mM HEPES-K, 0.5 mM EGTA,
pH 7) containing 2 mM DTT, inhibitors were added when
indicated, and further incubated for 5–15 min at 37jC.
After addition of stimulants to the sperm suspensions,
incubation proceeded at 37jC for 15 min. Ten microliters
of each reaction mixture were spotted on eight-well slides,
air dried, and fixed and permeabilized in ice-cold methanol
for 30 s. Acrosomal status was evaluated by staining with
fluorescein isothiocyanate-coupled Pisum sativum accord-
ing to Mendoza et al. (1992). At least 200 cells were scored
using a Nikon Optiphot II microscope (Nikon Corporation,
Tokyo, Japan) equipped with epifluorescence optics. Nega-
tive (no stimulation) and positive (10 AM calcium) controls
were included in all experiments. For each experiment, the
data were normalized by subtracting the number of reacted
spermatozoa in the negative control from all values and
expressing the result as a percentage of the AR observed in
the positive control.
Mouse sperm preparation procedure
Mouse sperm were obtained by rupturing the excised
caudae epididymides of mature Swiss outbred mice (Charles
River Breeding Co., Wilmington, MA or Harlan Sprague
Dawley, Indianapolis, IN) in 20 mM Tris–HCl pH 7.4, 130
mM NaCl, 2 mM CaCl2 (TNC buffer), washed once by
centrifugation at 100  g for 10 min, and lysed immediately
(noncapacitated samples) or resuspended in CM media (a
Krebs Ringer–bicarbonate medium supplemented with py-
ruvate, lactate, glucose, and 20 mg/ml BSA; Saling and
Storey, 1979). Capacitation was achieved by incubating
sperm (107 cells/ml) in CM for 60–120 min at 37jC in
5% CO2–95% air. Proteins from washed, noncapacitated
and capacitated sperm were extracted in 1% TX-100 lysis
buffer (see below) and processed for SDS-PAGE or PTP
assays. Soluble and particulate fractions were recovered bythe subcellular fractionation procedure detailed in Tomes et
al. (1996).
PTP assay
Sperm incubated and washed as described were lysed in
cold 50 mM Tris–HCl, pH 7.4, 150 mMNaCl, 2 mM EDTA,
2 mM DTT, 5 Ag/ml trypsin inhibitor, 5 Ag/ml pepstatin, 0.5
mM phenylmethylsulfonyl fluoride, 0.5 mM benzamidine,
1% TX-100. After sonication for 2  15 s and extraction for
30–60 min at 4jC, the sperm extracts were clarified by
centrifugation at 12,000  g for 5 min and used immediately
or stored at 20jC. PTP activity assays measure the release
of 32Pi from labeled substrate. Briefly, sperm extracts were
incubated with [32P]poly(Glu-Tyr) in a reaction mixture
(final volume 100 Al) containing 50 mM HEPES, pH 7.4, 1
mM EDTA, 2 mM DTT, and 2 mg/ml BSA for 10 min at
30jC. Reactions were stopped by precipitating the excess of
substrate with 20% ice-cold TCA. After incubating on ice for
15 min, pellets were recovered by centrifuging 10 min 
12,000 g and measuring the radioactivity released in 90 Al of
the supernatant. The protocol using RCML as PTP substrate
has been detailed elsewhere (Tonks et al., 1988a).
SDS-PAGE and Western blots
Proteins were extracted in PTP lysis buffer (Figs. 7G and
8B) or in sample buffer (Fig. 6; Tomes et al., 1998),
separated on polyacrylamide slab gels according to Laemmli
(1970) and transferred to 0.45 Am Immobilon (Millipore
Corp., Bedford, MA) membranes (Towbin et al., 1979).
Nonspecific reactivity was blocked by incubation for 1 h at
room temperature with 5% gelatin (PY20), 5% skim milk
(FG6), or 1% BSA (clone 15) dissolved in washing buffer
(Tomes et al., 1996). Blots were incubated with PY20 (0.2
Ag/ml), FG6 (1 Ag/ml), or clone 15 (1 Ag/ml) in blocking
solution for 60–120 min at room temperature. Horseradish
peroxidase-conjugated goat antimouse-IgG was used as
secondary antibody with 45-min incubations. Excess first
and second antibodies were removed by washing 5  10
min in washing buffer. Detection was accomplished with a
chemiluminescence system (ECL, Amersham Biosciences,
Piscataway, NJ) and subsequent exposure to Kodak XAR
film (Eastman Kodak, Rochester, NY) for 5–30 s.
Indirect immunofluorescence in SLO-permeabilized sperm
Sperm were permeabilized with SLO as described and
treated with 350 nM BoNT/E-LC (preactivated by incuba-
tion for 15 min at 37jC with 5 mM DTT) to prevent
exocytosis (Tomes et al., 2002). Following addition of
inhibitors, 10 AM free calcium and incubation at 37jC for
15 min, sperm pellets were washed in PBS and fixed and
permeabilized in 2% paraformaldehyde–0.1% TX-100 in
PBS for 10 min at room temperature. After centrifugation
(5000  g for 5 min), sperm were incubated in PBS
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pelleted, and washed twice with PBS containing 0.4%
polyvinylpyrrolidone (PVP, average M.W. = 40,000; ICN,
PBS/PVP). Sperm pellets were suspended in blocking solu-
tion (5% BSA in PBS/PVP) and incubated for 1 h at room
temperature. Antiphosphotyrosine antibodies 4G10 or PY20
were diluted 1:100 (10 Ag/ml) in blocking solution, added to
the sperm pellets, and incubated overnight at 4jC. After
washing with PBS/PVP (3), TRITC-goat antimouse IgG
(10 Ag/ml in 1% BSA in PBS/PVP) was added and incubated
for 1 h at RT. After washing as before, samples were spotted
on glass slides, mounted in Gelvatol, and examined with an
Eclipse TE300 Nikon microscope equipped with a Hama-
matsu Orca 100 camera operated with the MetaMorph
software (Universal Imaging Corp., USA). Alternatively,
smears were allowed to air dry, and stained with FITC–
PSA as done for AR assays. Samples were mounted in a
mixture of propylgalate–DABCO (3:1) or Gelvatol, and
examined in a Nikon C1 confocal microscope. Images were
recorded with the program EZ-C1 (Nikon) and processed
with MetaMorph.
Indirect immunofluorescence in non-SLO-permeabilized
sperm
Cells maintained in GPM for 3 h under capacitating
conditions were washed with PBS (2) and allowed to air
dry on 9-mm round coverslips before fixing in 2% parafor-
maldehyde and permeabilizing with 0.1% TX-100. All
following procedures were as described above, except that
an anti-PTP1B (FG6, 20 Ag/ml) IgG was used instead of the
antiphosphotyrosine antibodies.
Statistical analysis
Differences between experimental and control conditions
were tested by a two-way ANOVA and Fisher’s protected
least-significant difference tests. Percentages (not normal-
ized) were transformed to the arc sine before analysis. Only
significant differences (P < 0.05) between experimental
groups are discussed in the text.Results
Calcium stimulates protein tyrosine phosphorylation in
human sperm during the AR
Protein phosphorylation is a dynamic process in which
the phosphorylation state of a protein reflects the competing
action of kinases and phosphatases. Extensive investigation
in a variety of systems indicates that exocytosis is one
process that heavily depends on phosphorylation. A wide-
spread methodology in the study of exocytosis is the use of
SLO permeabilization, which we have recently applied to
the human sperm AR (Yunes et al., 2000). Permeabilizationallows entrance of exogenous proteins that usually are not
able to penetrate the plasma membrane and can be exploited
to block the function of target proteins. In the present report,
we use this strategy to analyze the role of protein tyrosine
phosphorylation in human sperm ARs. First, we investigat-
ed the localization of tyrosine-phosphorylated proteins in
SLO-permeabilized human sperm by indirect immunofluo-
rescence. The loss of tyrosine phosphorylation in the sperm
head during the AR would introduce an underestimation of
the level of phosphorylation achieved in response to a
calcium stimulus. To circumvent this problem, the final
events of the AR—fusion between the plasma and outer
acrosomal membranes but not the preceding signaling
cascade—was blocked by cleavage of the Q-SNARE pro-
tein SNAP-25 with His6-tagged BoNT/E-LC. The vast
majority of cells exhibited phosphotyrosine staining on
three different compartments of spermatozoa: the principal
piece (Fig. 1B, asterisk), the principal piece plus the whole
acrosome (Figs. 1B,F), and the principal piece plus the
equatorial segment (Fig. 1D). Double staining with FITC–
PSA and examination with a confocal microscope revealed
correspondence between the phosphotyrosine and the PSA
signals on the acrosomal region. Only acrosome-intact cells
(i.e. labeled with FITC–PSA; Figs. 1A, C, and E) displayed
tyrosine phosphorylation on the acrosomal region (Figs. 1B
and F) or in the equatorial segment (Fig. 1D) whereas
acrosome-reacted cells (i.e. not stained with FITC–PSA;
Fig. 1A, asterisk) failed to exhibit these patterns of staining
(Fig. 1B, asterisk). Identical results were observed when
another antiphosphotyrosine monoclonal antibody (4G10)
was used instead of PY20 (data not shown). The phospho-
tyrosine immunolocalization described here shows good
correspondence with that recently reported in nonpermea-
bilized human sperm (Ficarro et al., 2003; Sakkas et al.,
2003), suggesting that permeabilization of sperm plasma
membrane with SLO does not alter the detection of tyrosine-
phosphorylated proteins.
We reasoned that if this posttranslational modification
plays a role during the AR, then we should be able to detect
changes in tyrosine phosphorylation when we stimulate the
cells to undergo exocytosis. Following incubation under
capacitating conditions and SLO permeabilization, cells
were exposed to 350 nM of His6-tagged BoNT/E-LC to
minimize the onset of exocytosis before detection of phos-
photyrosine residues with the PY20 antibody. Lack of AR in
these cells was corroborated with FITC–PSA (Fig. 2B).
Under resting conditions, 19% of the cells exhibited phos-
photyrosine staining on the head (Fig. 2A, ‘‘control’’).
Challenging with calcium for 15 min doubled the percent-
age (37%) of cells depicting phosphotyrosine staining in this
region (Fig. 2A, ‘‘Ca’’). This increase was precluded by
preincubation (15 min) with the tyrosine kinase inhibitor
tyrphostin A47 before stimulating the cells (22%; Fig. 2A,
‘‘tyrpA47 + Ca’’). Despite these alterations in PY levels in
sperm heads, the percentage of the population undergoing
ARs remained largely unchanged (10–13%, panel B) as a
Fig. 1. Localization of tyrosine-phosphorylated proteins in SLO-permeabilized human sperm. After permeabilization with SLO, human sperm samples were
fixed, permeabilized, and exposed to the antiphosphotyrosine antibody PY20. Cells were dual labeled with a TRITC-coupled antimouse antibody (red staining,
B,D,F) and FITC–PSA (green staining, A,C,E). Two labeling patterns were detected on the sperm head, acrosomal (F and arrowheads in B) and equatorial
(arrowheads in D). All sperm present strong labeling in the principal piece of the flagellum. Acrosome-reacted sperm (asterisk in A) did not present head
staining (asterisk in B). The yellow acrosomal signal in panel G indicates overlap between the green and red signals seen in panels E and F. Shown are
fluorescence micrographs recorded with a confocal microscope. Scale bars are depicted in panels A, C, and E.
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kinase activity is significantly induced when the signaling
cascades leading to the AR are triggered by stimulating
sperm with calcium. The observed localization of phospho-
tyrosine residues on the sperm head is consistent with the
notion that this posttranslational modification plays a role in
sperm exocytosis.Protein tyrosine phosphorylation is required for human
sperm AR triggered by calcium and Rab3A
Based on the observation that calcium induces protein
tyrosine phosphorylation in sperm, we went on to analyze
the role of PTK in the human sperm AR. Our SLO
permeabilization approach allows us to separate the process
Fig. 2. Calcium elicits tyrosine phosphorylation in human sperm. (A) Human sperm were capacitated, SLO-permeabilized, and incubated for 15 min at 37jC in
the presence of 350 nM His6-BoNT/E-LC to block exocytosis. When indicated, aliquots were incubated F 80 AM tyrphostin A47 for 15 min at 37jC, followed
by 0.5 mM CaCl2 (10 AM free ion) and additional 15-min incubation. Afterward, cells were processed for indirect immunofluorescence using PY20 (10 Ag/ml)
as primary antibody. The percentage of labeled heads was calculated scoring the acrosomal (Fig. 1B, arrowheads) plus equatorial (Fig. 1D, arrowheads)
fluorescent patterns over the entire population of stained cells. At least 150 cells were scored per condition. The data represent the mean F SEM of three
independent experiments. (B) Acrosomal status of sperm treated as in A assessed with FITC–PSA. At least 400 cells were scored per condition.
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during and after permeabilization, cells are maintained in
conditions that do not support capacitation (low tempera-
ture, unsupplemented simple saline solutions, brief incuba-
tion). The separation of these two processes is mandatory to
reveal the role of tyrosine phosphorylation in acrosomal
exocytosis, a task that has proven difficult to investigate in a
heterogeneous population of intact sperm cells that are
engaged in capacitation as well as acrosomal exocytosis.
First, a specific antibody against phosphotyrosine (4G10)
was introduced into SLO-permeabilized human sperm be-
fore challenging with Ca2+ or GTP-loaded Rab3A. Addition
of GTP-loaded recombinant Rab3A to SLO-permeabilized
human sperm induced an exocytotic response of magnitude
comparable to that of Ca2+ (Fig. 3A, ‘‘Rab’’). Pretreatment
with the antiphosphotyrosine antibody inhibited the AR by
90% (Fig. 3A, ‘‘anti-PY + Ca’’, ‘‘anti-PY + Rab’’). Inhibi-
tion was not observed when the antibody was preincubated
with ortho-phospho-D,L-tyrosine (Fig. 3A, ‘‘antiPY* +
Ca’’), suggesting its inhibitory effect was specific due to
binding to endogenous phosphotyrosyl groups. These data
indicate that tyrosine-phosphorylated proteins are involved
in calcium- and Rab3A-triggered acrosomal exocytosis in
human sperm.
These observations do not allow us to distinguish wheth-
er the modification of tyrosine residues by PTK(s) occurs
before or after permeabilization and/or as a function of
sperm challenge with inducers. To discern between these
possibilities, permeabilized sperm cells were incubated with
the PTK inhibitors genistein and tyrphostins A47 and A51,
or with tyrphostin A1 as negative control, before Ca2+stimulation. Several different concentrations of each inhib-
itor were tested to determine the optimal inhibitory dose and
to minimize nonspecific effects. Thus, the calculated IC50
under our assay conditions were 85 AM for genistein and 29
AM for tyrphostin A47 (data not shown). The results in Fig.
3B show that calcium-triggered exocytosis was inhibited by
80% by 185 AM genistein, and by over 90% by 80 AM
tyrphostins A47 and A51. The inactive analog tyrphostin A1
had no effect. Our data suggest that active PTKs—and
therefore de novo phosphorylations—are required for calci-
um-triggered exocytosis in permeabilized human sperm.
Moreover, it is suitable to speculate that the calcium
stimulus is responsible—directly or indirectly—for the
activation of those PTKs.
Calcium triggers sperm protein tyrosine phosphorylation in
two waves, one before and one after the efflux of
intra-acrosomal calcium
In an attempt to refine our understanding of the sequence
of signaling events leading to the AR, we used a reversible
blocker of exocytosis that prevents the AR by sequestering
intra-acrosomal calcium (De Blas et al., 2002). The reversible
blocker of choice was the photolabile calcium chelator O-
nitrophenyl-EGTA (NP-EGTA). UV photolysis of NP-EGTA
releases the caged calcium rapidly and in high photochemical
yield (Ellis-Davies and Kaplan, 1994). In our SLO-permea-
bilized human sperm model, the membrane-permeable com-
pound NP–EGTA–AM crosses the plasma and outer
acrosomal membranes, accumulating inside the acrosome
and thus precluding the availability of intra-acrosomal calci-
Fig. 3. Protein tyrosine phosphorylation is required for human sperm AR.
(A) SLO-permeabilized human sperm were treated for 15 min at 37jC in
the presence of 10 Ag/ml (67 nM) of the antiphosphotyrosine antibody
4G10 pretreated (anti-PY* + Ca) or not (anti-PY + Ca) with 60 AM ortho-
phospho-D,L-tyrosine. Acrosomal exocytosis was evaluated by FITC–PSA
binding after an additional 15-min incubation at 37jC in the absence or
presence of 0.5 mM CaCl2 (10 AM free ion, grey bars) or 300 nM GTP-g-S-
bound Rab3A (black bars). (B) SLO-permeabilized human sperm were
treated for 15 min at 37jC in the presence of 185 AM genistein (gen), 80
AM tyrphostin A47 (tyrpA47), 80 AM tyrphostin A51 (tyrpA51), or 80 AM
tyrphostin A1 (tyrp A1). Acrosomal exocytosis was evaluated by FITC–
PSA binding after an additional 15-min incubation at 37jC in the presence
of 0.5 mM CaCl2 (10 AM free ion). The values were normalized as
described in Materials and methods. Actual percentages of reacted sperm
for negative (control, 0 mM CaCl2) and positive (Ca, 0.5 mM CaCl2, no
further additions) controls ranged between 17–25% and 27–36%,
respectively. The data represent the mean F SEM of at least three
independent experiments.
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previously shown that the occurrence of the calcium- and
Rab3A-triggered AR relies on the efflux of intra-acrosomal
calcium through IP3-sensitive calcium channels (De Blas etal., 2002). By combining the NP–EGTA–AM strategy with
the experimental approach described in Fig. 2, we assessed
whether a Ca2+-induced increase in sperm head tyrosine
phosphorylation takes place before or following intra-acro-
somal calcium efflux. When permeabilized cells were pre-
loaded with 10 AM NP–EGTA–AM, challenging with 10
AM calcium induced a moderate but significant (13–23%)
augmentation in tyrosine phosphorylation when the cells
remained in the dark (Fig. 4, ‘‘NP’’ vs. ‘‘NP!Ca’’). When
NP-EGTA was converted by UV flash to products with
negligible calcium affinity, the percentage of cells displaying
head staining increased even further (38%; Fig. 4,
‘‘NP!Ca!hr’’), reaching a level of staining comparable
to the maximum obtained with calcium in the absence of NP-
EGTA (42%; Fig. 4‘‘Ca’’). We interpret these two discrete
increases as a consequence of accumulative and sequential
phosphorylation events triggered by external and intra-acro-
somal calcium, respectively. Addition of tyrphostin A47 (80
AM) to cells treated previously with calcium had no effect on
the percentage of cells exhibiting tyrosine phosphorylation
on the head when the cells were kept in the dark (27%; Fig. 4,
‘‘NP!Ca!tyrpA47’’). In other words, tyrphostin—when
added after the stimulus—was unable to suppress the first
round of tyrosine phosphorylation elicited by external calci-
um. In contrast, tyrphostin abolished the additional increase
in tyrosine phosphorylation accomplished by UV illumina-
tion (28%; Fig. 4, ‘‘NP!Ca!tyrpA47!hr’’), maintaining
the percentage of stained heads identical to that of cells
challenged with calcium but not illuminated (23%; Fig. 4,
‘‘NP!Ca’’). In other words, tyrphostin suppressed phos-
phorylations that occurred because of PTKs activated by the
efflux of intra-acrosomal calcium. In summary, our data
support the notion that sperm head tyrosine phosphorylation
takes place in two waves, the first shortly after cytoplasmic
calcium increase and the second in a later step, achieved after
intra-acrosomal calcium efflux. The increase in tyrosine
phosphorylation appears to be due to calcium-triggered
PTK activation, which also takes place in two waves, one
before and one following intravesicular calcium release.
Remarkably, 10 AM cytosolic calcium is not sufficient to
elicit maximum tyrosine phosphorylation. Sperm must con-
tain PTKs that presumably require a specific microenviron-
ment for optimal activity, with higher and/or more localized
calcium concentrations achieved upon efflux of intra-acroso-
mal calcium. Alternatively, a component activated by intra-
acrosomal calcium release, instead of calcium itself, could be
responsible for the activation of these late-acting PTKs.
Protein tyrosine phosphorylation is required in the AR after
the efflux of intra-acrosomal calcium
To investigate the correlation between the calcium-in-
duced increase on sperm head tyrosine phosphorylation and
acrosomal exocytosis, we applied the NP-EGTA approach to
AR assays. Once again, the protocol allows for an AR
inducer to prepare the fusion machinery up to the point
Fig. 4. Calcium elicits two sequential rounds of tyrosine phosphorylation in human sperm. Human sperm were capacitated, SLO-permeabilized, and incubated
for 15 min at 37jC in the presence of 350 nM His6-BoNT/E-LC to block exocytosis. One aliquot was untreated (control), another was incubated 15 min at
37jC with 0.5 mM CaCl2 (10 AM free ion, Ca), and the rest was loaded with 10 AM NP–EGTA–AM for 15 min at 37jC in the dark. When indicated, 0.5 mM
CaCl2 was added and incubations proceeded for additional 15 min in the dark, followed by another 15 min incubation in the presence (NP!Ca!tyrpA47!)
or absence (NP!Ca!) of 80 AM tyrphostin A47. UV flash photolysis of the chelator was induced at the end of the incubation period (NP!hr, NP!Ca!hr,
NP!Ca!tyrpA47!hr). The rest of the tubes were not illuminated (NP!, NP!Ca!, NP!Ca!tyrpA47!). After a final 5-min incubation, samples were
processed for PY20 immunofluorescence as described. Percentage of head labeling was evaluated as explained in the legend to Fig. 2. The data represent the
mean F SEM of three independent experiments.
C.N. Tomes et al. / Developmental Biology 265 (2004) 399–415406when intra-acrosomal calcium release is required. This
calcium is kept unavailable by the chelator NP-EGTA. The
inhibitors to test are added, and finally release of the caged
calcium with a flash of UV light restores the intra-acrosomal
pool. Thus, if an inhibitor blocks exocytosis when added
after an inducer has initiated the AR, it suggests that the
target(s) of the inhibitor is required downstream of intra-Fig. 5. A late protein tyrosine phosphorylation event is required for human sperm
NP–EGTA–AM, followed by addition of 0.5 mM CaCl2 and incubated for 15 mi
and another illuminated at the end of the incubation (NP!Ca!hr). NP–EGTA–
Ag/ml) followed by addition of 0.5 mM CaCl2 and further incubation for 15 min at
loaded sperm were treated first with 0.5 mM CaCl2 and then with 10 Ag/ml of 4G
photolysis of the chelator was induced at the end of the incubation period. Bottom
with 185 AM genistein (gen), 80 AM tyrphostin A47 (tyrp A47), or 80 AM tyrp
(control, 0 mM CaCl2) and positive (Ca, 0.5 mM CaCl2) controls ranged between 1
at least three independent experiments.acrosomal calcium release. When permeabilized cells were
preloaded with 10 AM NP–EGTA–AM, challenging with
10 AM calcium failed to elicit exocytosis as long as the cells
were kept in the dark (Fig. 5, top, NP!Ca). When NP-
EGTA was converted by UV flash to products with negligi-
ble calcium affinity, exocytosis was restored (Fig. 5, top,
NP!Ca!hr). These data demonstrate that cytosolic calci-AR. Top bars: SLO-permeabilized human sperm were loaded with 10 AM
n at 37jC in the dark. As control, an aliquot was kept in the dark (NP!Ca)
AM-loaded sperm were treated F antiphosphotyrosine antibody 4G10 (10
37jC in the dark (NP!anti-PY!Ca!hr). Alternatively, NP–EGTA–AM-
10 and incubated as before (NP!Ca!anti-PY!hr). In all cases, UV flash
bars: Sperm were treated as described above, except that 4G10 was replaced
hostin A51 (tyrp A51). Actual percentages of reacted sperm for negative
5–34% and 24–54%, respectively. The data represent the mean F SEM of
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availability of intra-acrosomal calcium. Having shown the
requirement of tyrosine-phosphorylated proteins (Fig. 3) and
of intra-acrosomal calcium (Fig. 5, top; De Blas et al., 2002)
in the calcium-induced AR, we investigated the temporal
relationship between the two. First, we loaded permeabilized
sperm with the caged calcium buffer NP–EGTA–AM. In
one case, the antiphosphotyrosine antibody 4G10 was added
and the cells were preincubated for 15 min before addition of
calcium. Following these treatments, uncaging of intra-
acrosomal calcium was achieved by flash photolysis of the
NP–EGTA–AM (Fig. 5, top, ‘‘NP!anti-PY!Ca!hr’’).
As expected, AR was blocked since the inhibitor was present
throughout the experiment. In a second experimental setting,
we added calcium to NP–EGTA–AM-loaded sperm and
incubated for 15 min before addition of 4G10 in the dark.
UV flash photolysis of the calcium chelator was applied at
the end of the second incubation (Fig. 5, top, ‘‘NP!Ca!
anti-PY!hr’’). A complete blockage was also observed
under these conditions, indicating that tyrosine-phosphory-
lated proteins are acting downstream of the release of intra-
acrosomal calcium (Fig. 5, top series).
To distinguish between preexisting and de novo phos-
phorylation, genistein (185 AM) was used instead of 4G10.
The results in Fig. 5 (bottom series) show that genistein
blocks exocytosis, which is consistent with a kinase acting
downstream the intra-acrosomal calcium release. A require-
ment for activation of PTK in the AR at this late step was
further tested using two more PTK inhibitors, tyrphostin
A47 (80 AM) and tyrphostin A51 (80 AM), using an
identical strategy. Similar to 4G10, all three inhibitors
blocked the AR regardless of the sequence of addition
(Fig. 5, bottom series), suggesting that the AR relies on
the phosphorylation of crucial phosphotyrosine residues by
PTK on proteins whose role in fusion is played downstreamFig. 6. Enhanced protein tyrosine phosphorylation follows PTP inhibition by sod
exposed to 0 (lane 1), 10 (lane 2), 100 (lane 3), 500 (lane 4) and 1000 (lane 5) AM
using PY20 as probe. Protein corresponding to 1.6  106 cells was loaded per lan
Molecular weight standards (kDa) are indicated to the left of lane 1. (B) Effect o
Percentage of motility (circles) and viability (triangles) were scored for all sample
Human sperm were untreated (lane 1) or treated with 50 AM tyrphostin A47 (la
pervanadate (lane 4) in HTF for 3 h as described. Sperm were lysed, proteins extr
cells was loaded per lane. Shown is a blot representative of three experiments.of intra-acrosomal calcium release. Taken together, our data
confirm the requirement of tyrosine phosphorylation involv-
ing PTK activities in the AR. Furthermore, the observations
place a requirement for this posttranslational modification
late in the signaling cascade leading to sperm membrane
fusion.
Enhanced human sperm protein tyrosine phosphorylation
follows PTP inhibition by sodium pervanadate
Although there has been progress in the last decade in
dissecting tyrosine phosphorylation-related signaling path-
ways that are crucial for sperm function, surprisingly little
attention has been paid to the dynamics of the process. PTP
activity is of particular relevance since it can potentially
control the strength of phosphotyrosine-related pathways.
Therefore, we examined sperm PTP activity by analysis of
phosphotyrosine-containing proteins during capacitation in
the presence of a PTP inhibitor. To this end, we conducted
immunoblot experiments using the specific antiphosphotyr-
osine antibody PY20. When capacitated sperm were ex-
posed to different concentrations of vanadyl hydroperoxide
(pervanadate)—a membrane-permeant derivative of the in-
hibitor sodium orthovanadate—for 3 h, we observed a
stimulatory effect on protein tyrosine phosphorylation. With
regard to PY levels, pervanadate displayed a biphasic dose–
response curve, which was maximal at 100 AM and had
returned to control or lower levels at 1 mM (Fig. 6A). Sperm
viability was not affected (approximately 95% live cells
were observed in the presence of 2 mM pervanadate; Fig.
6B). Motility was quantitatively and qualitatively affected
only at pervanadate concentrations higher than 100 AM
(approximately 50% ‘‘twitching’’ sperm with 0.5 mM and
100% immotility with 1 mM after 3 h of treatment; Fig. 6B).
When the PTK inhibitor tyrphostin A47 was incorporatedium pervanadate. (A) After incubation in HTF for 5 h, human sperm were
pervanadate in HTF for 3 h prior to processing for Western blot analysis
e. The experiment was repeated three times, with similar results in each trial.
f pervanadate on the total motility and viability of human sperm samples.
s illustrated in panel A immediately before processing for Western blot. (C)
ne 2), 100 AM pervanadate (lane 3), or 50 AM tyrphostin A47 + 100 AM
acted, and analyzed by Western blot using PY20 as probe. Protein from 106
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ylation, a marked general decrease in protein tyrosine
phosphorylation was observed compared to the untreated
control (Fig. 6C, lanes 1 and 2). In contrast, when PTP
activity was abolished with 100 AM pervanadate, there was
a significant increase in the phosphotyrosine content of
sperm proteins (Fig. 6C, lane 3). The appearance of phos-
photyrosine in this situation appears to depend upon an
active PTK(s) since a combination of tyrphostin and perva-
nadate reversed protein tyrosine phosphorylation to levels
similar to those in the control (Fig. 6C, lane 4). None of
these treatments affected the percentage of live or motile
cells (approximately 90%), although sperm treated with
pervanadate exhibited less-vigorous motility. These data
show that reversible phosphorylation and dephosphorylation
takes place during human sperm capacitation. In addition,
they substantiate the notion that responses to pervanadate
are attributable to enhanced tyrosine phosphorylation. Fi-
nally, they identify robust PTP activity in human sperm
since their inhibition can enhance protein tyrosine phos-
phorylation even in conditions when PTK activity is main-
tained at a minimum.
PTP activity in human and mouse sperm
In view of the functional role of PTP in sperm protein
tyrosine phosphorylation, we undertook biochemical experi-
ments to further characterize this activity. First, we searched
for PTP activity in crude mixtures of whole human (Figs.
7A,B) and mouse (Figs. 7C–F) sperm extracts. Sperm
lysates from both sources generated high PTP activity when
measured with [32P]poly (Glu-Tyr) as substrate (Figs. 7A–
F). PTP activity was 2.5-fold higher in lysates from non-
capacitated compared to capacitated human sperm samples
(Figs. 7A,B). The enhanced tyrosine phosphorylation ob-
served in pervanadate-treated human sperm (Figs. 6 and 8)
suggests that its effect is exerted through inhibition of PTP
activity. To confirm this hypothesis, cells were treated withFig. 7. PTP activity in human and mouse sperm. (A) Noncapacitated (NC, grey cir
PTP activity measured in aliquots of the crude lysates using [32P]poly(Glu-Tyr) as s
(B) Noncapacitated (NC, grey bars) and capacitated (C, black bars) human sperm w
before homogenization. PTP activity was assessed as in A. Data (106 cells/assay) a
without pervanadate treatment (100%) and represent the mean F SEM from three
and capacitated (C, black circles) mouse sperm were homogenized and PTP acti
substrate. Data represent mean from ten experiments conducted in duplicate. (D) N
samples were homogenized and PTP activity measured in aliquots of the crude lysa
Data (106 cells/assay) are normalized respect to the activity exhibited by noncapac
conducted in duplicate. (E) PTP activity from noncapacitated mouse sperm lysate
increasing concentrations of pervanadate. Data are normalized with respect to activ
experiments conducted in triplicate. (F) Noncapacitated (NC, grey bars) and cap
soluble (sol) and particulate (part) fractions and tested for PTP activity with [32P]p
the particulate fraction of noncapacitated sperm (100%) and represent the mean
noncapacitated (lanes 1 and 3) and capacitated (lanes 2 and 4) mouse sperm cytoso
lane 5) were run in 10% SDS-gels, transferred and probed with the anti-PTP1B
migration of PTP1B is indicated by an arrow. Molecular weight standards (kDa) are
and immunostained with a mouse monoclonal anti-PTP1B antibody (clone FG
epifluorescence micrograph of three typically stained cells (bar = 6 Am).pervanadate and the PTP activity extracted from these cells
was determined. As seen in Fig. 7B, incubation of both
noncapacitated and capacitated sperm with pervanadate
completely inhibited PTP activity. Since previous reports
on the presence of these enzymes in male gametes have
been restricted to the identification of several cDNA sequen-
ces by PCR cloning in rodent libraries, we extended our
analysis to include the determination of PTP activity in
mouse sperm. As was the case in human sperm, PTP activity
was 1.8-fold lower in capacitated than in noncapacitated
mouse sperm (Figs. 7C,D). PTP activity partitioned into
both the soluble and particulate compartments of capacitated
and noncapacitated mouse sperm, perhaps reflecting the
contribution of more than one PTP (Fig. 7F). Membrane-
bound activity was 1.4-fold higher than that of the cytosolic
fraction. The influence of capacitation followed the same
pattern as that found in unfractionated sperm. As expected,
human (Fig. 7B) and mouse (Fig. 7E) PTP activities were
significantly inhibited by pervanadate. Random copolymers
of glutamate and tyrosine—such as poly(Glu-Tyr), ratio 4:1,
used throughout this study as PTP substrate—have been
shown to be noncompetitive inhibitors of several PTP iso-
forms (Tonks et al., 1988b). Therefore, to maximize detec-
tion of all PTP activities in sperm, we turned to RCML as
substrate. Similar to the previous results, extracts prepared
from capacitated mouse sperm displayed PTP activity 5.1-
fold lower than that from noncapacitated cells (Fig. 7D).
The characteristics of PTP activity measured with RCML
followed the same pattern as with the poly(Glu-Tyr) sub-
strate: activity was present in both the soluble and particu-
late fractions of mouse sperm with membrane-bound
fractions demonstrating higher activity than the cytosolic,
and capacitation decreased the activity in both fractions
(data not shown). These results indicate that mammalian
sperm exhibit substantial PTP activity and suggest that, in
addition to differential kinase activity, PTP activity changes
when cells are capacitated. To determine the presence of
specific PTP isoforms in mammalian sperm, we performedcles) and capacitated (C, black circles) human sperm were homogenized and
ubstrate. Data represent mean from five experiments conducted in triplicate.
ere preincubated with (pV) or without (control) 1 mM sodium pervanadate
re normalized with respect to the activity exhibited by noncapacitated sperm
experiments conducted in duplicate. (C) Noncapacitated (NC, grey circles)
vity measured in aliquots of the crude lysates using [32P]poly(Glu-Tyr) as
oncapacitated (NC, grey bars) and capacitated (C, black bars) mouse sperm
tes using [32P]poly(Glu-Tyr) (G-T)n and [
32P]RCML (RCML) as substrates.
itated sperm (100%) and represent the mean F SEM from two experiments
s (106 cells/assay) was assessed with [32P]poly(Glu-Tyr) in the presence of
ity in the absence of pervanadate (100%) and represent the mean from two
acitated (C, black bars) mouse sperm (106 cells/assay) were separated into
oly(Glu-Tyr). Data are normalized with respect to the activity exhibited by
F SEM from four experiments conducted in triplicate. (G) Proteins from
l (5  106cells/lane) and an unfractionated human sperm extract (106 cells,
antibodies clone 15 (lanes 1 and 2) and FG6 (lanes 3–5). Electrophoretic
indicated to the left of lane 1. (H) Human sperm were fixed, permeabilized,
6) followed by a TRITC-labeled goat antimouse antibody. Shown is an
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Fig. 8. PTP activity is required for human sperm AR. (A) Human sperm were capacitated, SLO-permeabilized, and incubated for 15 min at 37jC in the
presence of 350 nM His6-BoNT/E-LC to block exocytosis. Aliquots were incubated F30 AM sodium pervanadate (pV) or F0.5 mM CaCl2 (10 AM free ion,
Ca) for 15 min at 37jC. Afterward, cells were processed for indirect immunofluorescense using 10 Ag/ml PY20 as primary antibody. The percentage of labeled
heads was calculated as described in the legend to Fig. 2. The data represent the mean F SEM of two independent experiments. (B) Human sperm were
capacitated, SLO-permeabilized, and incubated for 15 min at 37jC in the presence of 350 nM His6-BoNT/E-LC to block exocytosis. One aliquot was untreated
(control) and another was incubated with 30 AM sodium pervanadate (pV) for 15 min at 37jC. Sperm were lysed, and proteins were extracted and analyzed by
Western blot using PY20 as probe. Protein from 2.2  106 cells was loaded per lane. Molecular weight standards (kDa) are indicated to the right. Shown is a
blot representative of three experiments. (C) SLO-permeabilized human sperm were treated for 15 min at 37jC in the presence of 30 AM pervanadate (pV), 10
AM phenylarsine oxide (PAO), 40 AMDMHV (DMHV), or 40 AM ethyl-3,4-dephostatin (dephost) plus 0.5 mM CaCl2 (10 AM free ion). Acrosomal exocytosis
was evaluated by FITC–PSA binding. The values were normalized as explained in Materials and methods. Actual percentages of reacted sperm for negative
(control, 0 mM CaCl2) and positive (Ca, 0.5 mM CaCl2, no further additions) controls ranged between 5–12% and 15–22%, respectively. The data represent
the mean F SEM of at least three independent experiments.
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specific for transmembrane and soluble enzymes. We
obtained a positive signal when probing with two mouse
monoclonal antibodies raised against human PTP1B
expressed in E. coli. FG6 detected a 50 kDa protein in
noncapacitated and capacitated mouse sperm cytosol and an
unfractionated human sperm extract (Fig. 7G, lanes 3, 4 and
5, respectively). Similarly, PTP1B was detected in the
cytosol of noncapacitated (Fig. 7G, lane 1) and capacitated
(Fig. 7G, lane 2) mouse sperm by a Transduction Labora-
tories antibody (clone 15). Neither antibody detected
PTP1B in the particulate fraction of either noncapacitated
or capacitated sperm (data not shown). Indirect immuno-
fluorescence experiments conducted with the FG6 mono-
clonal antibody indicate that PTP1B localizes to the mid-
piece of the flagellum and the equatorial segment of human
sperm (Fig. 7H). This study represents, to the best of our
knowledge, the first report describing PTP presence and
activity at the protein level in human sperm. Furthermore,
our findings support the notion that capacitation might
modulate tyrosine phosphorylation through the inhibition
of one or more PTPs.
PTP activity is required for calcium-triggered human sperm
AR
The data presented above demonstrate that protein
phosphorylation plays a fundamental role in regulating
acrosomal exocytosis in human sperm. In addition, theyindicate the sensitivity of human sperm PTPs to pervana-
date. Since considerable evidence suggests that PTPs can
exert both positive and negative effects on a signaling
pathway, we therefore set out to investigate the require-
ment of PTP in the AR. First, we inspected the subcellular
localization of tyrosine phosphorylation in cells where PTP
activity was suppressed by the use of pervanadate. When
capacitated human sperm were SLO-permeabilized, treated
with His6-tagged BoNT/E-LC to prevent exocytosis, and
subjected to indirect immunofluorescence with the PY20
antiphosphotyrosine antibody, a high percentage of cells
displayed strong, bright fluorescence restricted to the
principal piece of the flagellum. Fluorescence was ob-
served on the sperm head in a small subpopulation (7%)
of cells (Fig. 8A, ‘‘control’’). As before, treatment with
calcium induced a 4-fold increase (27%) in the percentage
of sperm depicting head-associated fluorescence (Fig. 8A,
‘‘Ca’’). Similarly, when sperm PTPs were inhibited by a
15-min treatment with sodium pervanadate, bright staining
could be detected on the head region in addition to the
principal piece in 26% of the cells (Fig. 8A, ‘‘pV’’).
Simultaneous treatment with calcium and pervanadate did
not increase the percentage of stained cells any further
(data not shown), perhaps reflecting saturation of the
system. The increase in protein tyrosine phosphorylation
in SLO-permeabilized cells accomplished by a brief PTP
inhibition with pervanadate was also detected by Western
blot in a variety of proteins (Fig. 8B). These data suggest
that sperm possess one or more active tyrosine kinases and
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vigorous concomitant phosphatase activity. Furthermore,
enhanced protein tyrosine phosphorylation secondary to
inhibition of PTP occurs during the restricted time frame
when sperm are primed to undergo the AR.
Last, we explored the possibility that PTP, as well as
PTK, might be involved in the AR. To this end, we
calculated the IC50 of four different PTP inhibitors in our
assay, which were 6.64 AM for pervanadate, 0.7 AM for
phenylarsine oxide (PAO), 3.74 AM for bis(N,N-dimethyl-
hydroxoamido)hydroxovanadate (DMHV), and 7.16 AM for
ethyl-3,4-dephostatin (data not shown). When permeabi-
lized human sperm were incubated with 30 AM pervanadate
and simultaneously challenged with Ca2+, a marked inhibi-
tion of sperm exocytosis was observed (Fig. 8C, ‘‘pV’’).
Because pervanadate inhibits other enzymes in addition to
PTP (Simons, 1979), we tested the effect of the more
specific PTP inhibitors PAO (10 AM), DMHV (40 AM),
and ethyl-3,4-dephostatin (40 AM). Treatment of permeabi-
lized sperm with all these inhibitors caused an almost
complete inhibition of the calcium-triggered AR (Fig. 8C).
These results suggest that PTP activity is necessary for
calcium to elicit acrosomal exocytosis. Taken together, our
data suggest that dynamic protein tyrosine phosphoryla-
tion—catalyzed by PTK and PTP—has an essential role in
human sperm acrosomal exocytosis.Discussion
Fertilization depends, among other things, upon the
regulated fusion of the acrosome with the spermatozoon’s
plasma membrane, leading to the exocytotic process termed
the AR. In several mammalian species, secretion is triggered
during gamete contact by ZP3, a glycoprotein component of
the zona pellucida (reviewed in McLeskey et al., 1998;
Wassarman, 1999; Wassarman et al., 2001). ZP3 produces a
sustained increase of the internal Ca2+ concentration, which
subsequently leads to the AR (Bailey and Storey, 1994;
O’Toole et al., 2000). Similarly, one of the nongenomic
effects of the steroid hormone progesterone is induction of
calcium influx and the AR of mammalian spermatozoa
(Aitken et al., 1996; Kirkman-Brown et al., 2000; Mendoza
et al., 1995).
Protein phosphorylation plays a central role in regulating
many cellular processes in eukaryotes. In particular, phos-
phorylation on tyrosyl residues has been shown to modulate
several aspects of sperm function. Although several labora-
tories have been concerned with unveiling the interplay
between calcium and tyrosine phosphorylation during acro-
somal exocytosis, the issue remains unresolved and many
contradictory findings are unexplained. For instance, mod-
ulation of T-type calcium channels in murine spermatogenic
cells by PTKs and PTPs has been reported (Arnoult et al.,
1997). In mouse sperm, tyrphostin A48 inhibits the ZP-
induced AR as well as the increase in intracellular calcium(Bailey and Storey, 1994). In contrast, treatment with
genistein or tyrphostin A47 has been shown to inhibit the
progesterone-induced AR of human sperm. Yet, these PTK
inhibitors have no effect on progesterone-triggered calcium
influx (Aitken et al., 1996; Kirkman-Brown et al., 2002;
Mendoza et al., 1995), suggesting that in this system PTKs
exert their effects on the AR at a site downstream of calcium
mobilization. On the other hand, src-related PTKs are
involved in the AR upstream of the capacitative calcium
entry (Dorval et al., 2003). In the present study, we
investigate the involvement of protein tyrosine phosphory-
lation during the calcium-dependent acrosomal exocytosis
in human sperm. We make use of a permeabilization
protocol developed in our laboratory which permits entry
of antibodies, recombinant proteins, Ca2+, and other mole-
cules into the cell (Diaz et al., 1996; Yunes et al., 2000).
This system is readily manipulated, reflects the in vivo
organization of the cell, and has been useful to demonstrate
roles for Rab3A (Yunes et al., 2000), NSF (Michaut et al.,
2000), synaptotagmin VI (Michaut et al., 2001), the SNARE
complex (Tomes et al., 2002), and calmodulin (Yunes et al.,
2002) in the Ca2+-dependent AR of human sperm. Further-
more, it has the important advantage of dissociating capac-
itation from exocytosis-linked changes. Previous studies
regarding the role of protein tyrosine phosphorylation on
the AR were restricted to inhibition of ZP- or progesterone-
induced sperm exocytosis by PTK inhibitors, some of them
not highly specific (reviewed in Baldi et al., 2002). Because
permeation of most of these inhibitors through cells’ plasma
membrane is slow, extensive incubation times are required
for intracellular diffusion. Consequently, it is difficult to
unequivocally ascertain whether a given inhibitor affects
capacitation or exocytosis. In contrast, the entrance of
inhibitors in permeabilized sperm is instantaneous and
incubations proceed in conditions that do not support
capacitation. When our experiments required the use of
inhibitors, we were careful to apply them in conditions
designed to minimize possible unspecific effects. To this
end, we performed dose–response curves and calculated the
IC50 for each PTK and PTP inhibitor in calcium-triggered
AR assays in SLO-permeabilized sperm. Applying this
criterion, we selected the minimum concentration of each
inhibitor that caused a maximal biological effect. These
concentrations were always V 10 IC50. Thus, we used 185
AM genistein (IC50 = 85 AM), 80 AM tyrphostin (IC50 = 29
AM), 30 AM pervanadate (IC50c7 AM), 10 AM PAO
(IC50c1 AM), 40 AM DMHV (IC50c0.4 AM), and 40
AM ethyl-3,4-dephostatin (IC50 = 7 AM). Our chosen con-
centrations of genistein, tyrphostins, pervanadate, and PAO
were similar or lower than those reported by others working
with mammalian sperm (Arnoult et al., 1997; Leclerc et al.,
1997; Leyton et al., 1992; Luconi et al., 1995; Mendoza et
al., 1995). Since our study constitutes the first report on the
use of ethyl-3,4-dephostatin and DMHVon sperm, we refer
to the IC50 reported by their manufacturer (3.2 and 22–27
AM, respectively).
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able to determine a substantial increase in protein tyrosine
phosphorylation on the head of unreacted human sperm
because of the activation by calcium of the signaling path-
ways leading to acrosomal exocytosis (Fig. 2A). Acrosomal
localization is what would be expected of a protein modi-
fication with a putative role in the AR. Phosphorylation
augmented by Ca2+ appears to be due to stimulation of
PTKs rather to inhibition of PTP, since tryphostin A47
reverses it completely. Whether calcium activates PTKs
directly or indirectly is currently unknown, as are the
kinases involved in the process. Interestingly, a calcium-
dependent tyrosine kinase, known variously as PYK2,
CAKb, or RAFTK, has recently been described in mouse
spermatozoa (Chieffi et al., 2003).
We have previously shown that the acrosome behaves as
a calcium storing organelle (De Blas et al., 2002). Release of
intravesicular calcium takes place after tethering of the
acrosome to the plasma membrane and is necessary for
human sperm AR. By using a photosensitive calcium
chelator in combination with a PTK inhibitor, we have been
able to reveal the existence of two components of tyrosine
phosphorylation: an early phase accomplished by addition
of external calcium, and a secondary phase that requires
efflux of intra-acrosomal calcium (Fig. 4). We hypothesize
that the first would be a consequence of the increase in
calcium that follows opening of voltage-sensitive and store-
operated channels in the plasma membrane. The second
phase would take place only after this increase in cytosolic
calcium elicits the efflux of more calcium from the acro-
some, and might reflect reactions that only take place in a
particular microenvironment characterized by highly local-
ized, elevated calcium concentrations.
Our functional assay shows that calcium-induced protein
tyrosine phosphorylation is essential for the human sperm
AR. The first line of evidence comes from the use of
antiphosphotyrosine antibodies. Treatment with 10 Ag/ml
4G10 resulted in inhibition of Ca2+-induced acrosomal
release (Fig. 3A), indicating a need for tyrosine-phosphor-
ylated proteins in the AR. This result also highlights the
high sensitivity of our assay, since in the only other related
study published, microinjection of 5 mg/ml of an antiphos-
photyrosine antibody was necessary to inhibit exocytosis of
GLUT4 transporters (Chen et al., 1997a). In human sperm,
the small GTPase Rab3 stimulates the AR to levels similar
to those attained with calcium (Yunes et al., 2000). Rab3-
stimulated secretion is also inhibited effectively by 4G10
(Fig. 3A), indicating that tyrosine-phosphorylated proteins
play a role downstream of the Rab3-triggered tethering of
the acrosome to the plasma membrane. The second line of
evidence on the role of protein tyrosine phosphorylation in
the AR comes from the use of PTK inhibitors. As shown in
Fig. 3B, loading of SLO-permeabilized sperm with genis-
tein, tyrphostin A47, or tyrphostin A51 reduced the sperm’s
exocytotic response to Ca2+. Since the identity of the
kinases involved is unknown, we chose to use a variety ofinhibitors because each appears to be selective for subsets of
enzymes rather than generic for all PTKs (Casnellie, 1991).
Furthermore, we selected drugs with different mechanisms
of action. Thus, genistein is an inhibitor competitive with
ATP whereas tyrphostins are competitive with protein and
peptide substrates (Casnellie, 1991). The fact that two
independent methods to block tyrosine phosphorylation
prevent ARs provides compelling evidence that calcium
utilizes a tyrosine kinase pathway to mediate acrosomal
exocytosis. The third line of evidence comes from the
combination of NP–EGTA–AM with antiphosphotyrosine
antibodies or PTK inhibitors. Our results indicate that
phosphotyrosine-containing proteins are required at or after
release of calcium from the acrosome (Fig. 5). It is worth
noting that the possibility of phosphotyrosine-containing
proteins playing a role in earlier steps during the AR is
not disputed by our data. These findings pose the exciting
question of whether these features are a signature of sperm’s
exocytotic cascade or represent a widespread, and as of yet
unexplored, phenomenon. Putative candidates for this late
role in fusion that have been shown to undergo tyrosine
phosphorylation in sperm and other systems include the
NSF analog valosin-containing protein (Ficarro et al., 2003),
the SNARE protein SNAP-25 (Zhou and Egan, 1997), and
synaptophysin (Pang et al., 1988).
Like most normal cells, resting sperm contain compara-
tively low levels of tyrosine-phosphorylated proteins, pre-
sumably reflecting the finding that overall PTP activity is
many orders of magnitude higher than overall PTK activity.
Indeed, increasing concentrations of pervanadate result in an
increase in phosphotyrosine on a number of intracellular
substrates in capacitating sperm (Fig. 6). This finding also
suggests that one or more PTK is constitutively active in
these cells. In fact, tyrphostin A47 significantly decreased
basal tyrosine phosphorylation as well as that stimulated by
pervanadate (Fig. 6C). Taken together, these results empha-
size the importance of PTP in the maintenance of tyrosine
phosphorylation during sperm capacitation. After capacita-
tion and SLO permeabilization, inhibition of PTP with a low
dose of pervanadate applied during a short time led to a
significant increase in protein tyrosine phosphorylation
(Figs. 8A,B), reflecting the presence of vigorous PTP
activity under these conditions. Although indirect evidence
concerning the presence of PTP activity in sperm, assessed
by an increase in tyrosine phosphorylation following treat-
ment with vanadate, has been reported by others (see for
instance Aitken et al., 1995; Berruti and Martegani, 1989;
Leclerc et al., 1997; Luconi et al., 1996), direct measure-
ment of this activity is lacking in the literature, except for
work from Shivaji’s laboratory, concerned mainly with
hamster sperm motility (Devi et al., 1999; Patil et al.,
2002). Several PTPs have been cloned from rat (Mizoguchi
and Kim, 1997) and mouse (Kaneko et al., 1993; Miyasaka
and Li, 1992a,b; Ohsugi et al., 1997; Park et al., 2000) testis
cDNA libraries; for some of them, spermatogenic cell
localization has been suggested. Here, we report the detec-
C.N. Tomes et al. / Developmental Biology 265 (2004) 399–415 413tion of PTP activity in whole cell extracts from mouse and
human sperm (Fig. 7). The observation that sperm incuba-
tion in capacitating conditions results in marked inhibition
of PTP activity is particularly attractive, since it provides a
plausible explanation for the increased protein tyrosine
phosphorylation observed by several laboratories in a num-
ber of species. We detected nontransmembrane PTP-1B by
Western blot in mouse and human sperm (Fig. 7G) and by
indirect immunofluorescence in human sperm (Fig. 7H).
Interestingly, there is partial overlapping in the localization
between PTP1B and its putative targets, tyrosine-phosphor-
ylated proteins (Fig. 1D, arrowheads). Although we do not
yet have evidence regarding the physiological role of this
enzyme in sperm, it is conceivable to speculate on a role of
this protein in secretion since it is enriched in secretory
granules (Wimmer et al., 1999) and modulates glucose
transporter GLUT4 translocation (Chen et al., 1997b).
Next, we investigated whether PTP activity plays a direct
role in the acrosomal exocytosis. As is the case with PTK,
the actual PTP is unknown. Therefore, we selected com-
pounds with different mechanisms of action to inhibit sperm
PTP activity. The hallmark of PTPs is an essential cysteine
residue at the catalytic site, which forms a thiol-phosphate
intermediate during catalysis (Guan and Dixon, 1991). Since
reducing conditions usually maintained by thiol reagents are
necessary for keeping the enzyme active, thiol-oxidizing
agents are potent PTP inhibitors. PAO forms a stable ring
complex with vicinal dithiols (Rokutan et al., 2000), whereas
pervanadate irreversibly promotes the oxidation of the cys-
teine group to cysteic acid (Huyer et al., 1997). Pervanadate
is the product of a mixture of orthovanadate and hydrogen
peroxide, which constitutes a more potent inhibitor of PTP
than orthovanadate, and penetrates cells more readily
(Kadota et al., 1987). Both PAO and pervanadate were
effective in inhibiting the AR (Fig. 8C). In addition to
pervanadate and PAO, we tested the recently described,
more specific PTP inhibitors DMHV (Cuncic et al., 1999)
and ethyl-3,4-dephostatin (Suzuki et al., 2001) and found
that they abolish the calcium-triggered AR as well (Fig. 8C),
supporting the suggestion that PTPs are involved in sperm
exocytosis. The fact that both PTK and PTP activities are
necessary for acrosomal exocytosis is intriguing. One pos-
sible explanation is that one or more tyrosine residues on the
proteins required for exocytosis need to cycle between a
phosphorylated and a dephosphorylated state to function
properly. Alternatively, certain tyrosine residues on protein
members of the fusion machinery might need to be phos-
phorylated while others might need to be dephosphorylated
to elicit exocytosis. Furthermore, note that, in addition to
controlling the phosphorylation states of PTK substrates,
PTPs can also directly modulate PTK activity (Haj et al.,
2003; Zhang et al., 2002b). Conversely, PTKs have been
shown to regulate PTP activity (Zhang et al., 2003). Inter-
estingly, serine and threonine—but not tyrosine—dephos-
phorylation have been shown to participate in the late phases
of membrane fusion in yeast (Bryant and James, 2003;Marash and Gerst, 2001; Peters et al., 1999). Which, if
any, of these processes is involved in the AR is currently
under investigation in our laboratory.
In short, sperm’s highly differentiated structure and
function renders it a likely candidate for the application of
a range of informative analyses to directly assess the role of
proteins in the exocytosis of preformed granules. In this
context, the beauty of our AR model is two-fold. Specifi-
cally, it allows the use of biochemical and molecular
biological techniques to understand fundamental aspects of
sperm biology that have not—so far—been successfully
addressed. And more generally, it may disclose widespread
pathways that have proven difficult to investigate in cells
that, in addition to exocytosis, exhibit other types of
membrane trafficking events such as endocytosis, mem-
brane recycling, and ER to Golgi transport.Acknowledgments
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